CVS (CVS)  recently announced plans to acquire Aetna (AET) for $69 billion in a move that is widely seen as an unprecedented merger of retail and healthcare.

But is the potential combo a reaction to Amazon's (AMZN) dive into healthcare? Amazon recently obtained wholesale distribution licenses from pharmaceutical boards in multiple states, including New Jersey, Connecticut, Michigan and Arizona. It's also reportedly in preliminary talks with generic drugmakers including Mylan NV and Sandoz (NVS) The question is, what will the master of disruption do next?

It's your move, Jeff Bezos. 

More of What's Trending on TheStreet:

 

N/A

More from Video

Abbott Downing Exec: 'There's a Missed Perception That Volatility Means Risk'

Abbott Downing Exec: 'There's a Missed Perception That Volatility Means Risk'

Jim Cramer to Elon Musk: 'No Lawyer in the World Would Say You Should Do This'

Jim Cramer to Elon Musk: 'No Lawyer in the World Would Say You Should Do This'

Abbott Downing Executive on New Years Resolutions for Investors

Abbott Downing Executive on New Years Resolutions for Investors

Jim Cramer: Why Uber and Lyft IPOs Are Bad for the Market

Jim Cramer: Why Uber and Lyft IPOs Are Bad for the Market

What Investors Need to Know About the Brexit Deal

What Investors Need to Know About the Brexit Deal